SEC Form 4 · accession 0001144204-17-033846
Accelerate Diagnostics, Inc · AXDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven Reichling
Officer — CHIEF FINANCIAL OFFICER
Period of report
Jun 21, 2017
Accepted (ET)
Jun 23, 2017 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000727207
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 21, 2017 | M | 30,000 | $2.98 | A | 30,700 | D | |
| Common Stock | Jun 21, 2017 | S | 30,000 | $28.90 | D | 700 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $2.98 | Jun 21, 2017 | M | 30,000 | D | — | Sep 10, 2022 | Common Stock | 30,000 | 170,000 | D |
Explanation of responses
- F1Forty percent (40%) of the shares underlying the option vested on September 10, 2014, with the balance vesting in thirty-six (36) equal monthly installements beginning on October 10, 2014 and ending on September 10, 2017. As of June 21, 2017, 190,000 shares underlying the options have vested.